Qaelum further extends its research team to strengthen innovation in radiology related quality monitoring

Research in Qaelum is key to stay in the forefront of medical quality management. As a growing company, we steadily extend our team of research experts. In September, An Dedulle started a PhD project within the team. This project, a Baekeland mandate, is funded by the Flemish Agency for Innovation and Entrepreneurship (VLAIO). The project focuses on personalized patient dosimetry and risk assessment in radiology.

A growing company… also in research!

Ever since we spun out from the University Hospitals in Leuven, we kept on growing. To stay ahead in a rapidly evolving field, we consistently invest in top-level research activities.

Our dedicated team of experts deals with a wide range of research topics, often in collaboration with the University Hospitals Leuven. The studies that are performed concern different medical imaging modalities, such as Computed Tomography (CT), but they are not limited to radiology. Our researchers systematically work on offering improved and efficient tools to our customers in order to ensure high quality levels. For example, dosimetric calculations in Qaelum’s DOSE solution are continuously optimised towards personalized dosimetry. Our ultimate goal is to maintain a high level of service and ensure patient safety by all means.

An Example of an experiment on a phantom in plexiglass. Using strategically positioned dosimeters, the radiation dose on the surface of this phantom, which mimics the human skin, can be monitored.

PhD student An Dedulle strengthens the team

An extra research boost is a new PhD project, for which we obtained funding from the Flemish Agency for Innovation and Entrepreneurship (VLAIO). It concerns a Baekeland Mandate that allows us to perform a PhD research project in close collaboration with the University of Leuven. On September 1, An Dedulle (master in physics and medical radiation physics) started working on a 4-year project, named “Personalised patient dosimetry and risk assessment in radiology”. The project – in collaboration with the department of radiology of UZ Leuven – focuses on finding a methodology to correlate the patient to a proper anatomical model. The target is that the approach will give more accurate patient-specific dose estimations than available today. In the longer run, the method may be implemented into our dose monitoring software to support a more patient-specific approach and relevant risk assessment.

Performing PhD-research in a company like Qaelum was a specific choice for An Dedulle: “Qaelum offers me the opportunity to perform my research together with the industry, which firmly increases the probability that my work will be implemented into clinical practice. I look forward to starting in Qaelum’s skilled and motivated research team”. Everyone at Qaelum welcomes An, and we all look forward to the results of the project.

Qaelum’s new research member, An Dedulle, performing experimental measurements in the radiology department of the University Hospitals Leuven